🇺🇸 FDA
Patent

US 7250171

Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein

granted A61KA61K2039/5256

Quick answer

US patent 7250171 (Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein) held by The United States of America as represented by the Secretary of the Dept. of Health & Human Services expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Dept. of Health & Human Services
Grant date
Tue Jul 31 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
70
CPC classes
A61K, A61K2039/5256